Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition
- 1 June 1995
- journal article
- Published by Springer Science and Business Media LLC in Nature Structural & Molecular Biology
- Vol. 2 (6), 442-445
- https://doi.org/10.1038/nsb0695-442
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Biological implications of a 3 å structure of dimeric antithrombinStructure, 1994
- Serpins: the uncut versionStructure, 1994
- Engineering Plasminogen Activator Inhibitor 1 Mutants with Increased Functional StabilityBiochemistry, 1994
- The intact and cleaved human antithrombin III complex as a model for serpin–proteinase interactionsNature Structural & Molecular Biology, 1994
- Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A .beta.-sheet of the inhibitor during trapping of target proteinasesBiochemistry, 1993
- Evidence for the extent of insertion of the active site loop of intact .alpha.1 proteinase inhibitor in .beta.-sheet ABiochemistry, 1992
- C1 inhibitor hinge region mutations produce dysfunction by different mechanismsNature Genetics, 1992
- Structural basis of latency in plasminogen activator inhibitor-1Nature, 1992
- Crystal structure of uncleaved ovalbumin at 1·95 Å resolutionJournal of Molecular Biology, 1991
- Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombinBritish Journal of Haematology, 1991